Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Giovanni Ribaudo, Alberto Ongaro, Erika Oselladore, Giuseppe Zagotto, Maurizio Memo & Alessandra Gianoncelli. (2022) A computational approach to drug repurposing against SARS-CoV-2 RNA dependent RNA polymerase (RdRp). Journal of Biomolecular Structure and Dynamics 40:3, pages 1101-1108.
Read now
Read now
Jeffrey Zhao, Carlos Galvez, Kathryn Eby Beckermann, Douglas B. Johnson & Jeffrey A Sosman. (2021) Novel insights into the pathogenesis and treatment of NRAS mutant melanoma. Expert Review of Precision Medicine and Drug Development 6:4, pages 281-294.
Read now
Read now
Articles from other publishers (18)
Jinlian Wei, Xin Chen, Yongyun Li, Ruoxi Li, Keting Bao, Liang Liao, Yuqing Xie, Tiannuo Yang, Jin Zhu, Fei Mao, Shuaishuai Ni, Renbing Jia, Xiaofang Xu & Jian Li. (2022) Cucurbitacin B-induced G2/M cell cycle arrest of conjunctival melanoma cells mediated by GRP78–FOXM1–KIF20A pathway. Acta Pharmaceutica Sinica B 12:10, pages 3861-3876.
Crossref
Crossref
David O. Holland, Valer Gotea, Kevin Fedkenheuer, Sushil K. Jaiswal, Catherine Baugher, Hua Tan, Michael Fedkenheuer & Laura Elnitski. (2022) Characterization and clustering of kinase isoform expression in metastatic melanoma. PLOS Computational Biology 18:5, pages e1010065.
Crossref
Crossref
Anuradha Reddy, Tarang Jadav, Amit Kumar Sahu & Pinaki Sengupta. (2022) LC–MS/MS bioanalytical method for quantification of binimetinib and venetoclax, and their pharmacokinetic interaction. Bioanalysis 14:2, pages 75-86.
Crossref
Crossref
Ozge Tatli & Gizem Dinler Doganay. (2021) Recent Developments in Targeting RAS Downstream Effectors for RAS-Driven Cancer Therapy. Molecules 26:24, pages 7561.
Crossref
Crossref
Paula Martínez-Fernández, Patricia Pose, Raquel Dolz-Gaitón, Arantxa García, Inmaculada Trigo-Sánchez, Enrique Rodríguez-Zarco, MJose Garcia-Ruiz, Ibon Barba, Marta Izquierdo-García, Jennifer Valero-Garcia, Carlos Ruiz, Marián Lázaro, Paula Carbonell, Pablo Gargallo, Carlos Méndez, Juan José Ríos-Martín, Alberto Palmeiro-Uriach, Natalia Camarasa-Lillo, Jerónimo Forteza-Vila & Inés Calabria. (2021) Comprehensive NGS Panel Validation for the Identification of Actionable Alterations in Adult Solid Tumors. Journal of Personalized Medicine 11:5, pages 360.
Crossref
Crossref
Jiangnan Dong, Su Li & Guangxuan Liu. (2021) Binimetinib Is a Potent Reversible and Time-Dependent Inhibitor of Cytochrome P450 1A2. Chemical Research in Toxicology 34:4, pages 1169-1174.
Crossref
Crossref
Keting Bao, Yongyun Li, Jinlian Wei, Ruoxi Li, Jie Yang, Jiahao Shi, Baoli Li, Jin Zhu, Fei Mao, Renbing Jia & Jian Li. (2021) Fangchinoline suppresses conjunctival melanoma by directly binding FUBP2 and inhibiting the homologous recombination pathway. Cell Death & Disease 12:4.
Crossref
Crossref
Cynthia Reyes Barron & Bruce R. Smoller. 2021. Practical Oncologic Molecular Pathology. Practical Oncologic Molecular Pathology
189
206
.
Bruna Dalmasso, Irene Vanni, William Bruno, Virginia Andreotti, Lorenza Pastorino, Francesco Spagnolo & Paola Ghiorzo. 2021. Current Management of Melanoma. Current Management of Melanoma
39
45
.
Matthias Drosten & Mariano Barbacid. (2020) Targeting the MAPK Pathway in KRAS-Driven Tumors. Cancer Cell 37:4, pages 543-550.
Crossref
Crossref
Yongsoo Kim, Tycho Bismeijer, Wilbert Zwart, Lodewyk F. A. Wessels & Daniel J. Vis. (2019) Genomic data integration by WON-PARAFAC identifies interpretable factors for predicting drug-sensitivity in vivo. Nature Communications 10:1.
Crossref
Crossref
Sophie Maiezza, Anna Greliak, Henry Abi Rached & Laurent Mortier. (2019) Exacerbation of skin psoriasis when associating an MEK inhibitor with anti-PD1 immunotherapy for metastatic melanoma. Melanoma Research 29:4, pages 447-448.
Crossref
Crossref
Sarah F. Barclay, Kyle W. Inman, Valerie L. Luks, John B. McIntyre, Alyaa Al-Ibraheemi, Alanna J. Church, Antonio R. Perez-Atayde, Shamlal Mangray, Michael Jeng, Sara R. Kreimer, Lori Walker, Steven J. Fishman, Ahmad I. Alomari, Gulraiz Chaudry, Cameron C. Trenor III, Denise Adams, Harry P. W. Kozakewich & Kyle C. Kurek. (2018) A somatic activating NRAS variant associated with kaposiform lymphangiomatosis. Genetics in Medicine 21:7, pages 1517-1524.
Crossref
Crossref
Paola Savoia, Paolo Fava, Filippo Casoni & Ottavio Cremona. (2019) Targeting the ERK Signaling Pathway in Melanoma. International Journal of Molecular Sciences 20:6, pages 1483.
Crossref
Crossref
Abdul Q. Khan, Shilpa Kuttikrishnan, Kodappully S. Siveen, Kirti S. Prabhu, Muralitharan Shanmugakonar, Hamda A. Al- Naemi, Mohammad Haris, Said Dermime & Shahab Uddin. (2019) RAS-mediated oncogenic signaling pathways in human malignancies. Seminars in Cancer Biology 54, pages 1-13.
Crossref
Crossref
Oxana Ryabaya, Anastasia Prokofieva, Roman Akasov, Dmitry Khochenkov, Marina Emelyanova, Sergey Burov, Elena Markvicheva, Andrey Inshakov & Evgenia Stepanova. (2019) Metformin increases antitumor activity of MEK inhibitor binimetinib in 2D and 3D models of human metastatic melanoma cells. Biomedicine & Pharmacotherapy 109, pages 2548-2560.
Crossref
Crossref
Thomas KnackstedtRebecca W. KnackstedtRafael CoutoBrian Gastman. (2018) Malignant Melanoma: Diagnostic and Management Update. Plastic & Reconstructive Surgery 142:2, pages 202e-216e.
Crossref
Crossref
Biao Lu, Song Huang, Jingsong Cao, Qiyue Hu, Ru Shen, Hong Wan, Dan Wang, Jijun Yuan, Lei Zhang, Jiayin Zhang, Minsheng Zhang, Weikang Tao & Lianshan Zhang. (2018) Discovery of EBI-1051: A novel and orally efficacious MEK inhibitor with benzofuran scaffold. Bioorganic & Medicinal Chemistry 26:3, pages 581-589.
Crossref
Crossref